Zoetis (ZTS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
22 May, 2026Opening remarks and agenda
Meeting commenced virtually with introductions of board members, executive officers, and independent auditors.
Shareholders were informed about voting procedures and access to meeting materials.
The agenda included five formal business items and a Q&A session.
Board and executive committee updates
Twelve director nominees were presented for election to serve one-year terms until the 2027 meeting.
Board recommended voting for all director nominees and for annual advisory votes on executive compensation.
Shareholder proposals
A shareholder proposal to permit action by written consent was presented and supported by its sponsor.
The board recommended voting against the proposal, citing reasons in the proxy statement.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Zoetis
- Q1 2026 revenue up 3% to $2.3B, adjusted net income up 2% to $646M, guidance 2%–5% growth.ZTS
Q1 202613 May 2026 - Driving animal health innovation and growth with a diverse portfolio and global scale.ZTS
Corporate presentation8 Apr 2026 - 2026 proxy details strong growth, governance, and sustainability, with key votes on directors and pay.ZTS
Proxy filing8 Apr 2026 - Key votes include director elections, say-on-pay, auditor ratification, and written consent rights.ZTS
Proxy filing8 Apr 2026 - Growth in 2026 will be led by parasiticides, innovation in long-acting therapies, and expanding franchises.ZTS
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Triple combination parasiticides and livestock drive growth amid resilient global demand.ZTS
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Strong product innovation and market expansion drive growth amid resilient pet health spending.ZTS
Leerink Global Healthcare Conference 20269 Mar 2026 - 2026 guidance reflects resilience, innovation, and a synchronized global reporting calendar.ZTS
BofA Securities Animal Health Summit26 Feb 2026 - 2025 saw 6% organic growth, robust franchises, and strong 2026 guidance for further gains.ZTS
Q4 202512 Feb 2026